Our Providers
Timothy L. Cannon, MD
Dr. Cannon is board certified in hematology, oncology, and internal medicine. He was the chief Hematology/Oncology fellow at New York University. He was named fellow of the year two out of three years (among 18 fellows). He has been published 4 times on topics including inflammatory breast cancer, hairy cell leukemia, and ovarian cancer.
Office Location(s):
Hematology-Oncology Associates of Fredericksburg
4501 Empire Court
Fredericksburg, Virginia 22408
Location Phone: 540-371-0079
Fax: 540-371-4254
Accepting new patients:
I am accepting new patients.
Undergraduate Education:
B.A., Chinese, Brigham Young University : 2001Medical Education:
M.D., UMDNJ- Robert Wood Johnson Medical School, Piscataway, NJ : 2005
Residency:
Internal Medicine Residency, George Washington University Hospital : 2008
Fellowship:
Hematology/Oncology Fellowship, New York University Hospital : 2011
Other Certifications:
New York – Medicine and Surgery Virginia – Medicine and Surgery
Board Certifications:
American Board of Internal Medicine, Medical Oncology : 2011American Board of Internal Medicine, Hematology : 2011
American Board of Internal Medicine : 2008
Languages other than English:
Mandarin
In Practice Since:
2011
Affiliations:
American Society of Clinical Oncology : 2009American Society of Hematology : 2008-present
Honors and Awards:
New York University Medical School : 2010-2011- Fellow of the Year, division of Hematology/Oncology
- Chief Fellow (for a fellowship of 18 Hematology/Oncology fellows)
New York University Medical School : 2009-2010
- Fellow of the Year, division of Hematology/Oncology
George Washington University Hospital : 2007
- Physician of the month
Brigham Young University : 1997-2000
- Six semester scholar athlete (basketball)
Publications:
Publication : 2011Cannon T, Muggia F, Bannan M, Kerr AR, Hirsh D, Downey A, Delacure M. Multi-focal Squamous Cell Carcinomas of the Oral Cavity in a Patient on Pegylated Liposomal Doxorubicin Maintenance. A Case Report. NYU Research Day Abstract 71.
Publication : 2011
Muggia F, Cannon T, Curtin J, Safra T. Delayed Neoplastic and Renal Complications in Women Receiving Long-term Chemotherapy for Recurrent Ovarian. JNCI 2011;103(2):160-165.
Publication : 2011
T. L. Cannon, F. Muggia, D. Hirsch, E. A. Andreopoulou, A. R. Kerr, M. D. DeLacure. Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer. J Clin Oncol 29: 2011(suppl;abstr 5557)
Publication : 2010
Levine PH, Zoflaghari L, Young H, Hafi M, Cannon T, Ganesen C, Veneroso C, Brem R Sherman M. What is Inflammatory Breast Cancer? Revisiting the Case Definition. Cancers 2010; 2(1):143-152.
Publication : 2008
Cannon T, Mobarek D, Wegge J, Tabbara I. Hairy Cell Leukemia: Current Concepts. Cancer Investigation 2008; 26:8 60-865.
